Curriculum vitae

Education

Tertiary

• Curtin University of Technology Perth, Western Australia
  Bachelor of Life Sciences (Molecular Genetics) with distinction. (Second overall in molecular genetics stream) (1997)
  Bachelor of Life Sciences (First class Honors) (1998)
  
• Curtin University of Technology Perth, Western Australia
  Commenced PhD (1999), expected graduation December 2002
  

Awards

• Golden Key National Honour Society Membership (1996-present)
• Best Student in Microbiology 331 Award (Australian Society for Microbiology, Western Australia Branch) (1998)
• Russell Pathology Honors Scholarship (1998)
• Australian Postgraduate Award with Stipend (1999-2002)

Laboratory Experience

As an undergraduate student I worked in Professor Warren Grubb's laboratory and became familiar with molecular biological techniques including cloning, DNA seqeuncing and plasmid isolation. In addition I worked in Dr John E. Gustafson's laboratory as an undergraduate examining the effects of salicylate on antibiotic resistance in Staphylococcus aureus. My current PhD research under the supervision of Dr John E. Gustafson has involved the use of a combination of physiological assays (antibiotic accumulation, MICs, autolysis), proteomics, bioinformatics and molecular biology to uncover the mechanisms underlying salicylate-inducible multiple drug resistance and other intrinsic antibiotic resistance mechanisms in Staphylococcus aureus.

Teaching experience

• Siemens Science Summer School, Curtin University (1999) (Instructor)
• Siemens Science Summer School, Curtin University (2000) (Instructor)
• Microbiology laboratory classes, Curtin University (1999-2000) (Instructor)
• Microbiology (lectures and laboratory classes) College of Dupage. (2001)

Publications

1. Gustafson J.E, Candelaria P.V, Fisher S.A, Goodridge J.P, Lichocik T.M, Mcwilliams T.M, Price C.T, O'Brien F.G. and Grubb W.B. (1999) Growth in the presence of salicylate increases fluoroquinolone resistance in Staphylococcus aureus. Antimicrobial. Agents and Chemotherapy. 43: 990-992.

2. Price, C. T. D, O'Brien, F.G, Shelton, B. P, Warmington, J. R, Grubb, W.B. and Gustafson J.E. (1999). Effects of salicylate and related compounds on fusidic acid MICs in Staphylococcus aureus . Journal of Antimicrobial Chemotherapy. 44: 57-64.

*errata appears in Journal of Antimicrobial Chemotherapy. 45: 415.

3. Price, C.T. and Gustafson, J. E. (2000). Increases in the mutation frequency at which fusidic acid-resistant Staphylococcus aureus arise with salicylate. Journal of Medical Microbiology. 50: 104-106.

4. Price, C.T, Lee, I. R. and Gustafson, J. E. (2000). The effects of salicylate on bacteria. International Journal of Biochemistry and Cell Biology. 32: 1029-1043.

5. Price, C.T.D, Kaatz, G.W, and Gustafson, J.E. (2002). The Multidrug Efflux Pump, NorA, is not Required for Salicylate-Induced Reduction in Drug Accumulation in Staphylococcus aureus. International Journal Antimicrobial Agents. 20: 212-219.

6. O'Brien, F.G, Price, C.T.D, Grubb, W.B, Gustafson, J.E. (2002). Genetic Characterization of the Fusidic Acid and Cadmium Resistance Determinants of Staphylococcus aureus plasmid pUB101. Journal of Antimicrobial Chemotherapy. 50: 313-321.

7. Price, C.T.D, Singh, V. K, Jayaswal, R.K, Wilkinson, B.J. and Gustafson, J.E. (2002). Pine Oil-Based Cleaner Resistant Staphylococcus aureus: Reduced Susceptibility to Vancomycin and Oxacillin and Involvement of SigB. Applied and Environmental Microbiology.68:5417-5421

Poster Presentations

J. E. Gustafson, P. V. Candelaria, S. A. Fisher, J. P. Goodridge, T. M. Lichocik, T. M. McWilliams, C. T. D. Price, F. G. O'Brien and W. B. Grubb. Effects of salicylate and related compounds on the expression of fluoroquinolone resistance in Staphylococcus aureus. (1998) 9th Annual Meeting of the Combined Biological Sciences, Perth, Australia.

O'Brien, F. G., C. D. T. Price, B. P. Shelton, J. R. Warmington, W. B. Grubb and J. E. Gustafson. Increase in fusidic acid resistance in Staphylococcus aureus grown in the presence of salicylate and related compounds. (1998) Australian Society for Microbiology Meeting.

Price, C.T. D. and Gustafson, J. E. Salicylate increases fusidic acid resistance and the frequency at which fusidic acid-resistant mutants arise from a -susceptible strain of Staphylococcus aureus. (1999) International Union of Microbiological Societies Meeting.

Price, C.T. D., O'Brien. F.G and Gustafson, J. E. Growth in the presence of salicylate reduces ciprofloxacin and ethidium bromide accumulation in Staphylococcus aureus (2000) 9th Symposium of Staphylococci and Staphylococcal Infections, Kolding, Denmark.

O'Brien, F. G, Grubb, W. B., Price, C. T. D. and John E. Gustafson. The complete sequence Of pUB101, an unusual Beta-lactamase plasmid from Staphylococcus aureus. (2001) Australian Society of Microbiology Meeting

Price, C. T. D, Kaatz, G. W., Foster, T. J. and Gustafson, J. E. Salicylate-Induced Multidrug Resistance in Staphylococcus aureus is Independent of NorA Expression. (2001) American Society of Microbiology Meeting, Orlando.

O'Brien, F. G, Price, C. T. D, Grubb, W. B., and John E. Gustafson. Cloning of fusidic acid and cadmium resistance determinants from the unique Staphylococcus aureus plasmid, pUB101. (2001) American Society of Microbiology Meeting, Orlando.

BACK